Christophe Sallaud

This inventor holds 1 USPTO granted patent. Top assignee: Genective, S.a.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christophe Sallaud. Retrieved from https://idiyas.com/inventor/christophe-sallaud-ynfn2ghh

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Christophe Sallaud: Innovator in Insecticidal Proteins

Introduction

Christophe Sallaud is a notable inventor recognized for his contributions to the field of insecticidal proteins. He has made significant strides in developing innovative solutions for pest control, which are crucial for agricultural advancements.

Latest Patents

Christophe holds a patent for "Insecticidal Proteins Compositions and Methods of Use." This patent showcases his expertise in creating effective compositions that can be utilized in various applications to combat insect pests.

Career Highlights

Christophe Sallaud is currently associated with Genective, S.A., a company that focuses on developing innovative agricultural solutions. His work at Genective has positioned him as a key player in the field of biotechnology and pest management.

Collaborations

Throughout his career, Christophe has collaborated with talented individuals such as Laurent Décousset and James Winsor. These partnerships have fostered a creative environment that encourages innovation and the development of new technologies.

Conclusion

Christophe Sallaud's contributions to the field of insecticidal proteins highlight his commitment to advancing agricultural practices. His innovative work continues to impact pest control methods positively.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…